Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $582.4M | $717.0M | $745.8M | $837.3M | $1.03B | $1.13B | $1.19B | $1.15B |
| Cost of revenue | $90.3M | $132.9M | $114.4M | $124.3M | $154.1M | $171.6M | $182.6M | $188.8M |
| Gross profit | $492.0M | $584.1M | $631.4M | $713.0M | $871.2M | $958.2M | $1.01B | $965.1M |
| Gross margin | 84.5% | 81.5% | 84.7% | 85.2% | 85.0% | 84.8% | 84.6% | 83.6% |
| R&D | $18.4M | $73.4M | $79.6M | $81.8M | $123.6M | $106.2M | $26.5M | $0 |
| Operating income | $70.6M | $137.2M | $112.3M | $119.7M | $108.7M | $125.6M | $122.1M | $105.7M |
| EBITDA | $111.4M | $185.1M | $176.3M | $192.5M | $214.0M | $228.3M | $212.8M | $206.9M |
| Net income | $31.3M | $92.3M | $65.8M | $73.2M | $69.0M | $73.4M | $45.9M | $34.6M |
| Net margin | 5.4% | 12.9% | 8.8% | 8.7% | 6.7% | 6.5% | 3.9% | 3.0% |
| EPS (diluted) | 0.63 | 1.85 | 1.33 | 1.36 | 1.30 | 1.40 | 0.88 | 0.67 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.0B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds CMPUY.
No tracked institution reports a position in CMPUY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-06-30 | $25.4104 | |
| 2024-05-23 | $1.0816 | 2024-06-11 |
No one on the platform has traded CMPUY yet.
| +0.00% |
| $1.6B |
| — |
| DWRKFDrägerwerk AG & Co. KGaA | $543.70 | +0.00% | $1.8B | — |
| KKPCFKaken Pharmaceutical Co., Ltd. | $26.00 | +0.00% | $985M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 25.8× earnings vs its 36.1× historical median P/E.
Fair value ≈ $34.69 · price $24.80 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.